Corporate Vice President and Chief Marketing Officer · IDEXX Laboratories Inc (IDXX)

Kathy Turner

A named executive officer of IDEXX Laboratories in every fiscal year CompBrief holds from FY2018 to FY2019. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2019

$2,696,822

Salary $409,692Stock awards $187,488

FY2018: $1,935,853

4th of 6 named executive officers at Idexx Laboratories by FY2019 total.

6 named officers on file for IDEXX Laboratories, FY2019

Kathy Turner’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 4 equity grants, each cited to its filing
  • IDXX’s disclosed peer group of 16 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how IDEXX Laboratories’s whole pay program stands against its peers

  • IDEXX Laboratories’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on IDXX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed March 26, 2020 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Kathy Turner’s full pay file as a PDF — free

More than this page: up to 10 years of Kathy’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Kathy Turner compensation by year

IDEXX Laboratories Summary Compensation Table · all 2 fiscal years held
In US dollars, as IDEXX Laboratories reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2018FY2019
Salary$387,500$409,692
Bonus$0$0
Stock awards$187,530$187,488
Option awards$562,012$562,374
Non-equity incentive$288,000$296,640
Pension and deferred compensation$0$0
All other$510,811$1,240,628
Total$1,935,853$2,696,822

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: IDEXX Laboratories Inc DEF 14A filed March 26, 2020, accession 0000874716-20-000013, and prior-year filings. Open the filing on EDGAR.

How this page was built: the IDEXX Laboratories Inc filed document, accession 0000874716-20-000013. Every figure is read from that document and cited to the page and table it appears in. Filed March 26, 2020.

$1.9M
$2.7M
FY18
FY19
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2019 year-end
TypeUnvested unitsValue at year-endExercise price
RSU906$236,584—
RSU841$219,610—
RSU635$165,818—
RSU442$115,419—
RSU188$49,092—
Option6,654—$141.60
Option8,849—$206.94
Option2,248—$79.54
Option8,566—$178.26
Option5,128—$67.85

Per the Outstanding Equity Awards at Fiscal Year-End table in IDEXX Laboratories Inc's FY2019 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

25 Form 4 lines since the FY2019 proxy (filed March 26, 2020)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2023-02-16Exercise or conversion derivative—10—3,726
2023-02-16Exercise or conversion—10$79.547,389.85
2023-02-16Sale—10$515.587,379.85
2023-02-15Exercise or conversion derivative—1,000—3,736
2023-02-15Sale—1,000$510.037,379.85
2023-02-14Exercise or conversion derivative—2,000—4,736
2023-02-14Exercise or conversion derivative—93—793
2023-02-14Tax withholding—293$503.657,379.85

The 8 most recent of 25 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

IDEXX Laboratories’s named executive officers, FY2019

as the company reported each
Named executive officerRoleFY2019 total
Jonathan AyersFormer Board Chair, President and Chief Executive Officer$8,188,764
Jonathan MazelskyPresident and Chief Executive Officer$7,419,335
Brian McKeonExecutive Vice President, Chief Financial Officer and Treasurer$3,940,306
Kathy Turner · this pageCorporate Vice President and Chief Marketing Officer$2,696,822
Sharon UnderbergCorporate Vice President, General Counsel and Corporate Secretary$1,809,228
Michael LaneExecutive Vice President and General Manager, Reference Laboratories and Information Technology$1,473,880

The full IDEXX Laboratories compensation record

free company brief

This page is one person within IDEXX Laboratories's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the IDEXX Laboratories proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are IDEXX Laboratories's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Kathy Turner's compensation dossier · One-time report. No refunds.